Recently added articles from Biotech Financial Reports:

TRANSAVE, INC. RAISES $35 MILLION VIA PREFERRED STOCK.

May 01, 2008 ... Transave, Inc., Monmouth Junction, N.J., a biopharmaceutical company focused on developing innovative inhaled pharmaceuticals for the site-specific treatment of serious lung diseases has raised an aggregate of $35 million pursuant to its recently completed preferred stock offering. Joining ...

NEOPHARM REPORTS 2007 4TH QTR NET LOSS OF $1.1 MILLION.(Financial report)

May 01, 2008 ... NeoPharm, Inc. (NASDAQ:NEOL), Waukegan, Ill., has announced its fourth quarter and full year 2007 financial results. For the fourth quarter ended December 31, 2007, NeoPharm reported a net loss of $1.1 million, or ($0.04) per basic and diluted share, as compared to a net loss of ...

REGENEREX REPORTS 2007 4TH QTR NET LOSS OF $3.5 MILLION.(Financial report)

May 01, 2008 ... RegeneRx Biopharmaceuticals, Inc. (AMEX:RGN), Bethesda, Md., has announced results for the fourth quarter and year ended December 31, 2007. The company reported a net loss of $11.2 million or $0.24 per share for the year ended December 31, 2007, compared with a net loss of $8.3 million or ...